3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Colorectal Neoplasms
18
Carcinoma, Hepatocellular
18
Stomach Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Squamous Cell Carcinoma of Head and Neck
9
Neoplasm Metastasis
9
Advanced Solid Tumor
9
Lung Neoplasms
7
Head and Neck Neoplasms
7
Rectal Neoplasms
5
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Melanoma
4
Solid Tumor
3
Lymphoma, Follicular
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Biliary Tract Neoplasms
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma
2
Hodgkin Disease
2
Interventions
Magnetic Resonance Spectroscopy
11
trametinib
8
selpercatinib
7
pembrolizumab
7
dabrafenib
7
Nivolumab
7
Iodine-131
6
lenvatinib
5
Specimen Handling
5
Biopsy
5
cabozantinib
4
Vemurafenib
4
Iodine-124
4
larotrectinib
3
durvalumab
3
binimetinib
3
anlotinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
pralsetinib
2
omipalisib
2
defactinib
2
copanlisib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
tislelizumab
×
1 year
×
Clear all
No trials found.